Subject category:
Finance, Accounting and Control
Published by:
Harvard Business Publishing
Version: 23 November 1992
Length: 12 pages
Data source: Published sources
Share a link:
https://casecent.re/p/47633
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This small but rapidly growing Danish biochemical company must choose among several financing opportunities that include a convertible Eurobond, a rights offering in Denmark and an issue of new common shares in the United States. The case involves a broad range of issues concerning the ability of a multinational company to lower its cost of capital by tapping different capital markets worldwide.
Locations:
Industries:
Size:
USD300 million sales
Other setting(s):
1981
About
Abstract
This small but rapidly growing Danish biochemical company must choose among several financing opportunities that include a convertible Eurobond, a rights offering in Denmark and an issue of new common shares in the United States. The case involves a broad range of issues concerning the ability of a multinational company to lower its cost of capital by tapping different capital markets worldwide.
Settings
Locations:
Industries:
Size:
USD300 million sales
Other setting(s):
1981